Arcutis and Sato announce strategic collaboration and licensing agreement for topical roflumilast in Japan
Arcutis Biotherapeutics, Inc. and Sato Pharmaceutical Co., Ltd., a leading pharmaceutical company, announced that the companies have entered into a strategic collaboration and licensing agreement for the development,… read more.
